Tumour-cell-derived SEMA3A was identified to inhibit the proliferation of protumoural M2 macrophages and promote the proliferation of antitumoural M1 macrophages, thereby recruiting and activating NK and cytotoxic CD8+ T cells to tumours [9]. Here, SEMA3A is linked to neoplasm.